-
OPC 2025: Early and Metastatic GI Cancers See Practice Changing Trial Results
20 Jun 2025 04:51 GMT
… recent clinical trial data shaping the treatment landscape for … the lack of FDA approval or formal inclusion … in patients with oligometastatic colorectal cancer who had undergone … Malignancies. Presented at: Oncology Pharmacists Connect; Austin, Texas; …
-
Brenus Pharma and InSphero Have Developed 3D Tumor Spheroids Mimicking in vivo Human Colorectal Cancer Conditions and Confirming STC-1010’s Efficacy
19 Jun 2025 07:30 GMT
… -1010, Brenus’ lead candidate for colorectal cancer.
Funded through the EUROSTARS program … active participants in their treatment.
www.brenus-pharma.com
About InSphero
InSphero … sets the standard for in vitro drug …
-
Immunotherapy Drugs Market Outlook 2025–2032: Growing Applications in Oncology to Drive beyond USD 398.16 Bn by 2032
19 Jun 2025 08:15 GMT
… Colorectal Cancer, Kidney Cancer, Others), Autoimmune Diseases, Others
■ By Distribution Channel: Hospital Pharmacies … , Retail Pharmacies, Online Pharmacies
Geographical Landscape of the Immunotherapy Drugs … 47;nanotechnology-drug-delivery- …
-
Oncoinvent reports positive data from phase 1/2a trial of Radspherin in patients with colorectal peritoneal metastases
19 Jun 2025 08:13 GMT
… originating from colorectal cancer.
Reducing peritoneal recurrence in colorectal cancer is critically … and often resulting in treatment interruptions and repeated hospitalizations. … ongoing phase 2 trial evaluating the treatment of peritoneal carcinomatosis …
-
For Patients with Multiple Cancers, a Colorectal Cancer Diagnosis Could be Lifesaving—or Life-Threatening
17 Jun 2025 19:10 GMT
CHICAGO — A new study using one of the world’s largest cancer registries shows that patient outcomes can be significantly impacted depending on when colorectal cancer (CRC) is diagnosed related to other cancers. The results are published in the Journal of …
-
These over-the-counter drugs are linked to rising bowel cancer cases in young adults
18 Jun 2025 14:17 GMT
… drugs — including pain relievers, indigestion medications, and hemorrhoid treatments— … medicine continues pushing pharmaceuticals that could be … a prescription for more pills.
Key findings on … mortality by 10% in colorectal cancer patients.
Paradoxically, …
-
Global Next-Gen Oncology Devices & Solutions Market to Hit $32.73B by 2029, Growing at 18.6% CAGR
20 Jun 2025 10:39 GMT
The Business Research Company's Next-Gen Oncology Devices & Solutions Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034
LONDON, GREATER LONDON, UNITED KINGDOM, June 20, 2025 /EINPresswire.com/ -- In the …
-
Cardiff Oncology Appoints Dr. Roger Sidhu as Chief Medical Officer and Announces Timing for the Next Update from the CRDF-004 Trial in First-Line RAS-mutated mCRC
17 Jun 2025 20:05 GMT
… for the treatment of first-line RAS-mutated metastatic colorectal cancer (“mCRC”) … a well-validated oncology drug target, to develop novel … be predictive of future trial results; our clinical trials … approvals and noncompliance with FDA regulations. There are …
-
Elicio Therapeutics to Host Virtual KOL Event on June 25, 2025 to Discuss AMP-Powered ELI-002 for the Treatment of KRAS mutation-driven Pancreatic Cancer
17 Jun 2025 12:00 GMT
… randomized Phase 2 trial for the adjuvant treatment of mKRAS-driven … new materials for vaccine and drug delivery. The major focus … and rapid availability of drug to patients especially in neo … in patients with mKRAS-positive colorectal cancer (“CRC”) in Phase 1 …
-
Dr Arnold on the Evaluation of Chemo With Amivantamab or Cetuximab in RAS/BRAF Wild-Type mCRC
19 Jun 2025 19:32 GMT
… ongoing phase 3 OrigAMI-2 trial (NCT06662786), which is … FOLFIRI, as first-line treatment for patients with left- … 47;BRAF wild-type metastatic colorectal cancer (mCRC).
OrigAMI-2 is … frontline treatment paradigm. He also noted that the trial complements …
About
© 1995-2025